Publications

5808 Results

Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival: a follow-up study to the NIH director's challenge leukemia and lymphoma molecular profiling project (LLMPP)

Authors
L Rimsza;R Roberts;T Miller;J Unger;M LeBlanc;R Braziel;D Weisenburger;WC Chan;T Greiner;K Muller-Hermelink;E Jaffe;RD Gascoyne;E Campo;D Fuchs;C Spier;R Fisher;L Staudt;T Grogan
Journal / Conference
Blood 102(11):(#1417)
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Loss of major histocompatibility class II (MHCII) expression in nodal diffuse large B cell lymphoma (DLBCL) is highly coordinated and unlikely related to chromosomal deletions

Authors
L Rimsza;R Roberts;E Campo;T Grogan;S Bea;I Salaverria;A Zettl;R Fisher;J Unger;M LeBlanc;L Staudt;R Gascoyne;W Chan;D Weisenburger;T Greiner;E Jaffe;R Braziel;K Muller-Hermelink;T Miller
Journal / Conference
Blood 102(11):(#3321)
Year
2003
Research Committee(s)
Lymphoma

Gene expression microarray analysis of de novo CD5+ diffuse large B-cell lymphoma (LLMPP study): a distinct entity?

Authors
RD Gascoyne;S Dave;A Zettl;S Bea;WC Chan;A Rosenwald;ES Jaffe;E Campo;J Delabie;D Weisenburger;G Ott;K Muller-Hermelink;L Rimsza;T Grogan;JM Connors;G Wright;LM Staudt
Journal / Conference
Blood 102(11):(#621)
Year
2003
Research Committee(s)
Lymphoma

Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky memorial lecture

Authors
JM Unger;M LeBlanc;JJ Crowley;HB Grossman;RB Natale;AJ Wozniak;JR Berenson;AF List;WA Peters III;RC Flanigan;JS Macdonald;M Al-Sarraf;IM Thompson;CA Coltman Jr
Journal / Conference
Journal of Clinical Oncology 21(23s):246s-252s
Year
2003

Effectiveness of a media based launch to recruit to a prostate cancer prevention trial

Authors
L Minasian;K Smigel-Croker;A Ryan;A Voss;L Cave;E Klein;L Ford
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:50S (#14)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

HLA D3(7) confers a poor prognosis in intermediate thickness (1.5-4.0mm) melanoma: serotyping of 553 patients on SWOG 9035.

Authors
JA Sosman;J Unger;JE Lee;P Liu;L Flaherty;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 22:710(#2856)
Year
2003
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

High dose dexamethasone (Dex) with maintenance Dex/alpha interferon lead to improved survival in patients with primary systemic amyloidosis: results of US Intergroup Trial Southwest Oncology Group (SWOG) S9628.

Authors
M Dhodapkar;J Jacobson;M Hussein;RA Larson;J Crowley;A Solomon;B Barlogie
Journal / Conference
Proc of the American Society of Clinical Oncology 22:566(#2278)
Year
2003
Research Committee(s)
Myeloma
Study Number(s)
S9628

Induction chemoradiotherapy and surgical resection for non-small cell lung carcinomas of the superior sulcus (pancoast tumors): mature results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)

Authors
VW Rusch;D Giroux;MJ Kraut;J Crowley;M Hazuka;DH Johnson;L Shulman;F Shepherd;D Deschamps;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 22:634(#2548)
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9416

Optimizing data collection in a large web-based trial

Authors
KB Gower;A Darke
Journal / Conference
Controlled Clinical Trials 24(3S):47S(#10)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Planning for successful recruitment for cancer trials

Authors
K Anderson;J Probstfield;SM Thomas
Journal / Conference
Controlled Clinical Trials 24(3S)Suppl:102S(#P18)
Year
2003
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000